295 related articles for article (PubMed ID: 21067354)
21. Seasonal influenza vaccination and the 2009 pandemic.
Mercer G; Kelly H
Clin Infect Dis; 2011 Mar; 52(6):828-9; author reply 830-1. PubMed ID: 21367738
[No Abstract] [Full Text] [Related]
22. Seasonal flu vaccination in Dutch at-risk populations was not affected by A(H1N1) 2009 pandemic vaccination.
Tacken MA; Mulder J; Verheij RA; Heijnen ML; Campbell SM; Braspenning JC
Prev Med; 2011 Feb; 52(2):184-5. PubMed ID: 21167198
[No Abstract] [Full Text] [Related]
23. Influenza: options to improve pandemic preparation.
Rappuoli R; Dormitzer PR
Science; 2012 Jun; 336(6088):1531-3. PubMed ID: 22723412
[TBL] [Abstract][Full Text] [Related]
24. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
Collin N; de Radiguès X;
Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
[TBL] [Abstract][Full Text] [Related]
25. Head-to-head comparison of pandemic influenza vaccines.
Leroux-Roels G; Leroux-Roels I
Lancet Infect Dis; 2011 Feb; 11(2):74-5. PubMed ID: 21168368
[No Abstract] [Full Text] [Related]
26. Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.
Crowe BA; Brühl P; Gerencer M; Schwendinger MG; Pilz A; Kistner O; Koelling-Schlebusch K; Aichinger G; Singer J; Zeitlinger M; Müller M; Ehrlich H; Barrett PN
Vaccine; 2010 Dec; 29(2):166-73. PubMed ID: 21055500
[TBL] [Abstract][Full Text] [Related]
27. A note on the use of influenza vaccination strategies when supply is limited.
Lee S; Morales R; Castillo-Chavez C
Math Biosci Eng; 2011 Jan; 8(1):171-82. PubMed ID: 21361406
[TBL] [Abstract][Full Text] [Related]
28. [Pandemic vaccines].
Floret D
Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
[No Abstract] [Full Text] [Related]
29. H1N1: can a pandemic cycle be broken?
Settembre EC; Dormitzer PR; Rappuoli R
Sci Transl Med; 2010 Mar; 2(24):24ps14. PubMed ID: 20375006
[TBL] [Abstract][Full Text] [Related]
30. Building an insurance against modern pandemics.
Rappuoli R; Medini D; Siena E; Budroni S; Dormitzer PR; Del Giudice G
Curr Opin Investig Drugs; 2010 Feb; 11(2):126-30. PubMed ID: 20112161
[TBL] [Abstract][Full Text] [Related]
31. Phylogenetic analysis of pandemic 2009 influenza A virus circulating in the South American region: genetic relationships and vaccine strain match.
Goñi N; Moratorio G; Ramas V; Coppola L; Chiparelli H; Cristina J
Arch Virol; 2011 Jan; 156(1):87-94. PubMed ID: 20931251
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of vaccination strategies during pandemic outbreaks.
Bowman CS; Arino J; Moghadas SM
Math Biosci Eng; 2011 Jan; 8(1):113-22. PubMed ID: 21361403
[TBL] [Abstract][Full Text] [Related]
33. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
Choo AY; Broderick KE; Kim JJ; Sardesai NY
IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
[TBL] [Abstract][Full Text] [Related]
34. Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009.
McVernon J; Nolan T
Expert Rev Vaccines; 2011 Jan; 10(1):35-43. PubMed ID: 21162618
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.
Dikow R; Eckerle I; Ksoll-Rudek D; Hampel H; Schwenger V; Zeier M; Schnitzler P; Sommerer C
Am J Kidney Dis; 2011 May; 57(5):716-23. PubMed ID: 21349617
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
[TBL] [Abstract][Full Text] [Related]
37. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.
Bickel M; Wieters I; Khaykin P; Nisius G; Haberl A; Stephan C; Von Hentig N; Herrmann E; Doerr HW; Brodt HR; Allwinn R
AIDS; 2010 Jun; 24(9):F31-5. PubMed ID: 20559034
[TBL] [Abstract][Full Text] [Related]
38. The 2009 Provincial decision to de-emphasize seasonal influenza vaccine in Canada: real-time risk-benefit analysis.
Kendall PR
Clin Infect Dis; 2011 Mar; 52(6):829-30; author reply 830-1. PubMed ID: 21367739
[No Abstract] [Full Text] [Related]
39. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
[TBL] [Abstract][Full Text] [Related]
40. China boosts pandemic surveillance.
Qiu J
Nature; 2009 Aug; 460(7259):1066. PubMed ID: 19713902
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
